Medrobotics Corporation
Other, 475 Paramount Dr, Raynham, Massachusetts, 02767, United States, 51-200 Employees
Phone Number: 50********
Who is MEDROBOTICS CORPORATION
Medrobotics manufactures and markets the Flex Robotic System, the worlds first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex Robotic System offers cl...
Read More
-
Headquarters: 475 Paramount Dr, Raynham, Massachusetts, 02767, United States
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
CEO:
Samuel Straface
Email
Phone
SIC Code: 
Does something look wrong? Fix it. | View contact records from MEDROBOTICS CORPORATION
Medrobotics Corporation Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Medrobotics Corporation
Answer: Medrobotics Corporation's headquarters are located at 475 Paramount Dr, Raynham, Massachusetts, 02767, United States
Answer: Medrobotics Corporation's phone number is 50********
Answer: Medrobotics Corporation's official website is https://medrobotics.com
Answer: Medrobotics Corporation's revenue is $25 Million to $50 Million
Answer: Medrobotics Corporation's SIC: 3841
Answer: Medrobotics Corporation's NAICS: 339112
Answer: Medrobotics Corporation has 51-200 employees
Answer: Medrobotics Corporation is in Other
Answer: Medrobotics Corporation contact info: Phone number: 50******** Website: https://medrobotics.com
Answer: Medrobotics manufactures and markets the Flex Robotic System, the worlds first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex Robotic System offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D HD visualization through a single entry point. Once the target disease is accessed, the Flex Robotic System provides a stable platform through which articulating flexible instruments are introduced providing consistent triangulation in hard-to-reach anatomical locations that might otherwise be inaccessible with traditional surgical instruments and difficult to treat with current endoscopic instruments. The companys vision is to provide more patients with access to endoluminal treatment options. Medrobotics received FDA clearances for the Flex Robotic System for ENT applications in July 2015 and for transanal applications in May 2017. The CE mark was issued in March 2014.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month